U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
Nendocabtagene Onogedleucel
INN  
Official Name English
ALLO 715
Preferred Name English
ALLO 715 [WHO-DD]
Common Name English
nendocabtagene onogedleucel [INN}
Common Name English
allogeneic T lymphocytes obtained from peripheral blood mononuclear cells by leukapheresis of healthy volunteer donors, transduced with a self-inactivating, non-replicating lentiviral vector encoding a chimeric antigen receptor (CAR) targeting human B-ce
Common Name English
ALLO-715
Code English
ALLO715
Code English
Anti-BCMA CAR T-cell therapy ALLO715
Common Name English
Notes: Allogenic T-cells expressing a chimeric antigen receptor directed to the B-cell maturation antigen (BCMA) for anticipated use in treating patients with multiple myeloma
Common Name English
Code System Code Type Description
FDA UNII
Q137JC2CLV
Created by admin on Wed Apr 02 08:40:23 GMT 2025 , Edited by admin on Wed Apr 02 08:40:23 GMT 2025
PRIMARY
SMS_ID
300000033830
Created by admin on Wed Apr 02 08:40:23 GMT 2025 , Edited by admin on Wed Apr 02 08:40:23 GMT 2025
PRIMARY
NCI_THESAURUS
C165779
Created by admin on Wed Apr 02 08:40:23 GMT 2025 , Edited by admin on Wed Apr 02 08:40:23 GMT 2025
PRIMARY
CAS
2783320-97-6
Created by admin on Wed Apr 02 08:40:23 GMT 2025 , Edited by admin on Wed Apr 02 08:40:23 GMT 2025
PRIMARY
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966